Détail d'une personne de l'annuaire - fr | Cancéropôle Est, la recherche innovante dans la lutte contre le cancer

Evaluation of the management of intracystic papillary carcinoma.

Beck M, Beltjens F, Arnould L, Coutant C, Vincent L

Bull Cancer. 2023 05 11;:

Impact of therapeutic strategy on disease-free and overall survival of early-stage cervical cancer: Surgery alone versus preoperative radiation.

Mahiou K, Vincent L, Peignaux-Casasnovas K, Costaz H, Padeano MM, Amet A, Dabakuyo S, Mamguem Kamga A, Bengrine-Lefevre L, Coutant C

Cancer Rep (Hoboken). 2023 04 19;:e1823

Axillary pathologic response after neoadjuvant chemotherapy and surgery according to breast cancers subtypes and survival impact.

Jankowski C, Michel E, Vincent L, Beltjens F, Arnould L, Ladoire S, Coutant C

Bull Cancer. 2023 04 18;:

HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study.

Kada Mohammed S, Billa O, Ladoire S, Jankowski C, Desmoulins I, Poillot ML, Coutant C, Beltjens F, Dabakuyo S, Arnould L

Breast Cancer. 2023 01 30;:

Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network).

Sebbag C, Rousset-Jablonski C, Coussy F, Ray-Coquard I, Garin C, Evrevin C, Cessot M, Labrosse J, Laot L, Darrigues L, Bobrie A, Sénéchal-Davin C, Espié M, Giacchetti S, Plu-Bureau G, Maitrot-Mantelet L, Gompel A, Santulli P, Asselain B, Hotton J, Coutant C, Guerin J, Decanter C, Mailliez A, Brain E, Dumas E, Sablone L, Seintinelles RN, Reyal F, Hamy AS

Breast. 2022 12 31;67:62-70

Cognitive change in breast cancer patients up to 2 years after diagnosis.

Lange M, Arbogast SL, Hardy-Léger I, Rigal O, Le Fel J, Pistilli B, Petrucci J, Lévy C, Capel A, Coutant C, Médeau L, Lerebours F, Vanlemmens L, Brion M, Bourbouloux E, Blain M, Binarelli G, Vaz-Luis I, Giffard B, Querel O, Everhard S, André F, Charles C, Dauchy S, Joly F

J Natl Cancer Inst. 2022 12 26;:

Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry.

Kada Mohammed S, Dabakuyo Yonli TS, Desmoulins I, Manguem Kamga A, Jankowski C, Padeano MM, Loustalot C, Costaz H, Causeret S, Peignaux K, Rouffiac M, Coutant C, Arnould L, Ladoire S

Breast Cancer Res Treat. 2022 11 23;:

Critical analysis of the effect of various methodologies to compute breast cancer tumour blood flow-based texture features using first-pass F-FDG PET.

Payan N, Presles B, Truntzer C, Courcet E, Coutant C, Desmoulins I, Brunotte F, Vrigneaud JM, Cochet A

Phys Med. 2022 10 16;103:98-107

Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study.

Houvenaeghel G, de Nonneville A, Cohen M, Classe JM, Reyal F, Mazouni C, Faure C, Martinez A, Chauvet MP, Daraï E, Coutant C, Colombo PE, Gimbergues P, Azuar AS, Rouzier R, Tunon de Lara C, Crochet P, Rua S, Gonçalves A

Eur J Cancer. 2022 10 1;176:58-69

Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol.

Assogba ELF, Dumas A, Woronoff AS, Mollévi C, Coutant C, Ladoire S, Desmoulins I, Dabakuyo-Yonli TS,

BMJ Open. 2022 09 28;12(9):e056834

The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastases.

Houvenaeghel G, de Nonneville A, Chopin N, Classe JM, Mazouni C, Chauvet MP, Reyal F, Tunon de Lara C, Jouve E, Rouzier R, Daraï E, Gimbergues P, Coutant C, Azuar AS, Villet R, Crochet P, Rua S, Bannier M, Cohen M, Boher JM

Cancer Med. 2022 09 20;:

Contraceptive Use in Premenopausal Women With Early Breast Cancer.

Lambertini M, Massarotti C, Havas J, Pistilli B, Martin AL, Jacquet A, Coutant C, Coussy F, Mérimèche AD, Lerebours F, Rousset-Jablonski C, Jouannaud C, Rigal O, Fournier M, Soulie P, Franzoi MA, Del Mastro L, Partridge AH, André F, Vaz-Luis I, Di Meglio A

JAMA Netw Open. 2022 09 1;5(9):e2233137

Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.

Soldato D, Havas J, Crane TE, Presti D, Lapidari P, Rassy N, Pistilli B, Martin E, Del Mastro L, Martin AL, Jacquet A, Coutant C, Cottu P, Merimeche A, Lerebours F, Tredan O, Vanlemmens L, André F, Vaz-Luis I, Di Meglio A

Cancer. 2022 08 1;:

Comparison of postoperative complications following conventional latissimus dorsi flap versus muscle-sparing latissimus dorsi flap breast reconstruction.

Fauconnier MB, Burnier P, Jankowski C, Loustalot C, Coutant C, Vincent L

J Plast Reconstr Aesthet Surg. 2022 07 23;:

Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: the CANTO study.

Baker JL, Di Meglio A, Gbenou AS, El Mouhebb M, Iyengar NM, Michiels S, Cottu P, Lerebours F, Coutant C, Lesur A, Tredan O, Vanlemmens L, Jouannaud C, Hrab I, Everhard S, Martin AL, Arveux P, Fabrice A, Vaz-Luis I, Jones LW

Br J Cancer. 2022 06 17;:

Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy.

Di Meglio A, Havas J, Gbenou AS, Martin E, El-Mouhebb M, Pistilli B, Menvielle G, Dumas A, Everhard S, Martin AL, Cottu PH, Lerebours F, Coutant C, Lesur A, Tredan O, Soulie P, Vanlemmens L, Joly F, Delaloge S, Ganz PA, André F, Partridge AH, Jones LW, Michiels S, Vaz-Luis I

J Clin Oncol. 2022 Apr 21;:JCO2100277

Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France.

Charles C, Bardet A, Larive A, Gorwood P, Ramoz N, Thomas E, Viari A, Rousseau-Tsangaris M, Dumas A, Menvielle G, Everhard S, Martin AL, Gbenou SY, Havas J, El-Mouhebb M, Di Meglio A, André F, Pistilli B, Coutant C, Cottu P, Mérimèche A, Lerebours F, Tredan O, Vanlemmens L, Jouannaud C, Levy C, Vaz-Luis I, Michiels S, Dauchy S

JAMA Netw Open. 2022 Apr 1;5(4):e225118

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis.

Vaz-Luis I, Di Meglio A, Havas J, El-Mouhebb M, Lapidari P, Presti D, Soldato D, Pistilli B, Dumas A, Menvielle G, Charles C, Everhard S, Martin AL, Cottu PH, Lerebours F, Coutant C, Dauchy S, Delaloge S, Lin NU, Ganz PA, Partridge AH, André F, Michiels S

J Clin Oncol. 2022 Mar 15;:JCO2101958

Change in the value of work after breast cancer: evidence from a prospective cohort.

Caumette E, Di Meglio A, Vaz-Luis I, Charles C, Havas J, de Azua GR, Martin E, Vanlemmens L, Delaloge S, Everhard S, Martin AL, Merimeche AD, Rigal O, Coutant C, Fournier M, Jouannaud C, Soulie P, Cottu PH, Tredan O, Menvielle G, Dumas A

J Cancer Surviv. 2022 Mar 10;:

Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.

Ladoire S, Rederstorff E, Goussot V, Parnalland S, Briot N, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F

Eur J Cancer. 2022 Feb 1;165:13-24

Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care.

Di Meglio A, Havas J, Soldato D, Presti D, Martin E, Pistilli B, Menvielle G, Dumas A, Charles C, Everhard S, Martin AL, Coutant C, Tarpin C, Vanlemmens L, Levy C, Rigal O, Delaloge S, Lin NU, Ganz PA, Partridge AH, André F, Michiels S, Vaz-Luis I

J Clin Oncol. 2022 Jan 21;:JCO2101252

[Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)].

Mathelin C, Barranger E, Boisserie-Lacroix M, Boutet G, Brousse S, Chabbert-Buffet N, Coutant C, Daraï E, Delpech Y, Duraes M, Espié M, Golfier F, Hamy AS, Kermarrec E, Lavoué V, Lodi M, Luporsi É, Maugard C, Molière S, Seror JY, Taris N, Uzan C, Vaysse C, Fritel X

Gynecol Obstet Fertil Senol. 2021 Dec 15;:

[Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)].

Mathelin C, Barranger E, Boisserie-Lacroix M, Boutet G, Brousse S, Chabbert-Buffet N, Coutant C, Daraï E, Delpech Y, Duraes M, Espié M, Fornecker L, Golfier F, Grosclaude P, Hamy AS, Kermarrec E, Lavoué V, Lodi M, Luporsi É, Maugard CM, Molière S, Seror JY, Taris N, Uzan C, Vaysse C, Fritel X

Gynecol Obstet Fertil Senol. 2021 Dec 14;:

Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study.

Houvenaeghel G, Cohen M, Classe JM, Reyal F, Mazouni C, Chopin N, Martinez A, Daraï E, Coutant C, Colombo PE, Gimbergues P, Chauvet MP, Azuar AS, Rouzier R, Tunon de Lara C, Muracciole X, Agostini A, Bannier M, Charaffe Jauffret E, De Nonneville A, Goncalves A

ESMO Open. 2021 Dec 1;6(6):100316

Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.

Costaz H, Boulle D, Bertaut A, Rouffiac M, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Causeret S, Loustalot C, Padeano MM, Vincent L, Jankowski C, Arnould L, Coutant C

Bull Cancer. 2021 Nov 24;:

Lymphovascular space invasion and Estrogen Receptor status in high-grade serous ovarian cancer-a multicenter study by the FRANCOGYN group.

Lorenzini J, Deberti M, Body G, Carcopino X, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Mimoun C, Bendifallah S, Ouldamer L,

J Gynecol Obstet Hum Reprod. 2021 Oct 26;:102242

Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).

Jochum F, De Rozario T, Lecointre L, Faller E, Boisrame T, Dabi Y, Lavoué V, Coutant C, Touboul C, Bolze PA, Bricou A, Canlorbe G, Collinet P, Huchon C, Bendifallah S, Ouldamer L, Mezzadri M, Querleu D, Akladios C

Int J Gynecol Cancer. 2021 Oct 4;:

Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue.

Lapidari P, Djehal N, Havas J, Gbenou A, Martin E, Charles C, Dauchy S, Pistilli B, Cadeau C, Bertaut A, Everhard S, Martin AL, Coutant C, Cottu P, Menvielle G, Dumas A, Andre F, Michiels S, Vaz-Luis I, Di Meglio A

Breast Cancer Res Treat. 2021 Sep 24;:

[Surgery or not on an atypical breast lesion? Taking anxiety into account in shared decision support from a prospective cohort of 300 patients].

Favier A, Boinon D, Salviat F, Mazouni C, Korvin B, Tunon C, Salomon AV, Doutriaux-Dumoulin I, Vaysse C, Marchal F, Boulanger L, Chabbert-Buffet N, Zilberman S, Coutant C, Espié M, Cortet M, Boussion V, Cohen M, Fermeaux V, Mathelin C, Michiels S, Delaloge S, Uzan C, Charles C

Gynecol Obstet Fertil Senol. 2021 Sep 22;:

[Surgical oncologists an "endangered species"].

Barranger E, Coutant C, Marre P, Salmon R

Bull Cancer. 2021 Sep 20;:

Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous,low grade serous and low grade endometrioid ovarian cancer.

Delvallée J, Cancel M, Body G, Bendifallah S, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Ballester M, Carcopino X, Mimoun C, Darai E, Ouldamer L

J Gynecol Obstet Hum Reprod. 2021 Jul 2;:102193

Lymphovascular space invasion as a prognostic factor of epithelial ovarian cancer: a multicenter study by the FRANCOGYN group.

Lorenzini J, Cirier J, Body G, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Ballester M, Carcopino X, Mimoun C, Bendifallah S, Ouldamer L,

Arch Gynecol Obstet. 2021 Jun 29;:

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study.

Mamguem Kamga A, Billa O, Ladoire S, Poillot ML, Jolimoy G, Roignot P, Coutant C, Desmoulins I, Maynadie M, Dabakuyo-Yonli TS

Breast. 2021 Jun 11;59:79-86

Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort.

Houvenaeghel G, de Nonneville A, Cohen M, Chopin N, Coutant C, Reyal F, Mazouni C, Gimbergues P, Azuar AS, Chauvet MP, Classe JM, Daraï E, Martinez A, Rouzier R, de Lara CT, Lambaudie E, Barrou J, Goncalves A

ESMO Open. 2021 May 10;6(3):100151

Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group.

Lecointre L, Bund V, Sangnier E, Ouldamer L, Bendifallah S, Koskas M, Bolze PA, Collinet P, Canlorbe G, Touboul C, Huchon C, Coutant C, Faller E, Boisramé T, Gantzer J, Demarchi M, Lavoué V, Akladios C

Ann Surg Oncol. 2021 Apr 26;:

Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France.

Blay JY, Boucher S, Le Vu B, Cropet C, Chabaud S, Perol D, Barranger E, Campone M, Conroy T, Coutant C, De Crevoisier R, Debreuve-Theresette A, Delord JP, Fumoleau P, Gentil J, Gomez F, Guerin O, Jaffré A, Lartigau E, Lemoine C, Mahe MA, Mahon FX, Mathieu-Daude H, Merrouche Y, Penault-Llorca F, Pivot X, Soria JC, Thomas G, Vera P, Vermeulin T, Viens P, Ychou M, Beaupere S

ESMO Open. 2021 Apr 17;6(3):100134

Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and Impact on patients.

Nambot S, Bertolone G, Sawka C, Cosset E, Goussot V, Derangère V, Boidot R, Baurand A, Robert M, Coutant C, Loustalot C, Thauvin-Robinet C, Ghiringhelli F, Lançon A, Populaire C, Damette A, Collonge-Rame MA, Meunier-Beillard N, Lejeune C, Albuisson J, Faivre L

Eur J Med Genet. 2021 Mar 19;:104196

Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group.

Rocher G, Gaillard T, Uzan C, Collinet P, Bolze PA, Ballester M, Bendifallah S, Ouldamer L, Touboul C, Huchon C, Lavoue V, Dabi Y, Akladios C, Coutant C, Raimond E, Bricou A, Canlorbe G, Azaïs H

J Clin Med. 2021 Mar 4;10(5):

Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer.

Lapidari P, Gbenou A, Havas J, Martin E, Pistilli B, Martin AL, Everhard S, Coutant C, Cottu P, Lesur A, Lerebours F, Tredan O, Vanlemmens L, Jouannaud C, Levy C, Rigal O, Fournier M, Andre F, Vaz-Luis I, Di Meglio A

Breast. 2021 Mar 2;57:43-48

Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.

Ladoire S, Goussot V, Redersdorff E, Cueff A, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hanu R, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F

Eur J Cancer. 2021 Feb 27;148:359-370

[Para-aortic lymph node staging in grade IB2 and above cervical cancers: comparison of 18FDG PET-CT with para-aortic lymphadenectomy, using data from the Côte d'Or gynaecological cancer registry from 2003 to 2016].

Carre A, Sellier J, Kamga AM, Dabakuyo S, Rouffiac M, Coutant C

Gynecol Obstet Fertil Senol. 2021 Jan 20;:

Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group.

Mimoun C, Paoletti X, Gaillard T, Crestani A, Benifla JL, Mezzadri M, Bendifallah S, Touboul C, Bricou A, Dabi Y, Canlorbe G, Kerbage Y, Lavoué V, Ouldamer L, Lecointre L, Coutant C, Fauconnier A, Rouzier R, Huchon C

PLoS One. 2021 ;16(10):e0258783

Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.

Zilliox M, Lecointre L, Azais H, Ballester M, Bendifallah S, Bolze PA, Bourdel N, Bricou A, Canlorbe G, Carcopino X, Chauvet P, Collinet P, Coutant C, Dabi Y, Dion L, Gauthier T, Graesslin O, Huchon C, Koskas M, Lavoue V, Mezzadri M, Mimoun C, Ouldamer L, Raimond E, Touboul C, Lapointe M, Akladios C

Eur J Obstet Gynecol Reprod Biol. 2020 Nov 13;256:412-418

Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub-study of the French CANTO cohort.

Hardy-Leger I, Charles C, Lange M, Joly F, Roux P, Capel A, Petrucci J, Rigal O, Fel JL, Vanlemmens L, Everhard S, Anne-Laure M, Vaz Luis I, Coutant C, Cottu P, Levy C, Lerebours F, Andre F, Licaj I, Dauchy S

Psychooncology. 2020 Oct 14;:

Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions.

Uzan C, Mazouni C, Rossoni C, De Korvin B, de Lara CT, Cohen M, Chabbert N, Zilberman S, Boussion V, Vincent Salomon A, Espie M, Coutant C, Marchal F, Salviat F, Boulanger L, Doutriaux-Dumoulin I, Jouve E, Mathelin C, de Saint Hilaire P, Mollard J, Balleyguier C, Joyon N, Triki ML, Delaloge S, Michiels S

Ann. Surg. Oncol.. 2020 Sep 12;:

Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN).

Bund V, Lecointre L, Velten M, Ouldamer L, Bendifallah S, Koskas M, Bolze PA, Collinet P, Canlorbe G, Touboul C, Huchon C, Coutant C, Faller E, Boisramé T, Gantzer J, Demarchi M, Baldauf JJ, Ballester M, Lavoué V, Akladios C

J Clin Med. 2020 Jul 29;9(8):

Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study.

Simon J, Chaix M, Billa O, Kamga AM, Roignot P, Ladoire S, Coutant C, Arveux P, Quantin C, Dabakuyo-Yonli TS

Br. J. Cancer. 2020 Jul 17;:

Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group.

Gaudet Chardonnet A, Azaïs H, Ballester M, Raimond E, Bendifallah S, Ouldamer L, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Lavoue V, Koskas M, Uzan C, Canlorbe G

Ann. Surg. Oncol.. 2020 Jul 9;:

Cognitive impairment in breast cancer patients before surgery: results from a CANTO cohort subgroup.

Lange M, Hardy-Léger I, Licaj I, Pistilli B, Rigal O, Le Fel J, Lévy C, Capel A, Coutant C, Meyer J, Lerebours F, Petrucci J, Vanlemmens L, Brion M, Campone M, Soulié P, Blain M, Vaz-Luis I, Giffard B, Martin AL, Everhard S, André F, Dauchy S, Joly F

Cancer Epidemiol. Biomarkers Prev.. 2020 Jul 1;:

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk.

Pistilli B, Paci A, Ferreira AR, Di Meglio A, Poinsignon V, Bardet A, Menvielle G, Dumas A, Pinto S, Dauchy S, Fasse L, Cottu PH, Lerebours F, Coutant C, Lesur A, Tredan O, Soulie P, Vanlemmens L, Jouannaud C, Levy C, Everhard S, Arveux P, Martin AL, Dima A, Lin NU, Partridge AH, Delaloge S, Michiels S, André F, Vaz-Luis I

J. Clin. Oncol.. 2020 Jun 22;:JCO1901758

Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial.

Mamguem Kamga A, Di Martino C, Anota A, Paget-Bailly S, Coutant C, Arveux P, Desmoulins I, Dabakuyo-Yonli TS

Trials. 2020 Jun 16;21(1):527

What Are Young Women Living Conditions after Breast Cancer? Health-Related Quality of Life, Sexual and Fertility Issues, Professional Reinsertion.

Assogba ELF, Kamga AM, Costaz H, Jankowski C, Dumas A, Roignot P, Jolimoy G, Coutant C, Arveux P, Dabakuyo-Yonli TS

Cancers (Basel). 2020 Jun 12;12(6):

Isolated lymph node recurrence in epithelial ovarian cancer: Recurrence with better prognosis?

Delangle R, Rossard L, Cirier J, Delvallée J, Bendifallah S, Touboul C, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Ballester M, Darai E, Body G, Ouldamer L,

Eur. J. Obstet. Gynecol. Reprod. Biol.. 2020 Apr 24;:

Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group.

Vincent L, Jankowski C, Ouldamer L, Ballester M, Bendifallah S, Bolze PA, Akladios C, Costaz H, Lavoué V, Canlorbe G, Collinet P, Touboul C, Huchon C, Bricou A, Dridi S, Padéano MM, Bengrine L, Arnould L, Coutant C,

Eur J Surg Oncol. 2020 Apr 24;:

Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study.

Di Meglio A, Michiels S, Jones LW, El-Mouhebb M, Ferreira AR, Martin E, Matias M, Lohmann AE, Joly F, Vanlemmens L, Everhard S, Martin AL, Lemonnier J, Arveux P, Cottu PH, Coutant C, Del Mastro L, Partridge AH, André F, Ligibel JA, Vaz-Luis I

Breast. 2020 Apr 11;52:23-32

Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF.

Akladios C, Azais H, Ballester M, Bendifallah S, Bolze PA, Bourdel N, Bricou A, Canlorbe G, Carcopino X, Chauvet P, Collinet P, Coutant C, Dabi Y, Dion L, Gauthier T, Graesslin O, Huchon C, Koskas M, Kridelka F, Lavoue V, Lecointre L, Mezzadri M, Mimoun C, Ouldamer L, Raimond E, Touboul C

J Gynecol Obstet Hum Reprod. 2020 Apr 1;:101729

[COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la FEMme (SIFEM),

Gligorov J, Bachelot T, Pierga JY, Antoine EC, Balleyguier C, Barranger E, Belkacemi Y, Bonnefoi H, Bidard FC, Ceugnart L, Classe JM, Cottu P, Coutant C, Cutuli B, Dalenc F, Darai E, Dieras V, Dohollou N, Giacchetti S, Goncalves A, Hardy-Bessard AC, Houvenaeghel G, Jacquin JP, Jacot W, Levy C, Mathelin C, Nisand I, Petit T, Petit T, Poncelet E, Rivera S, Rouzier R, Salmon R, Scotté F, Spano JP, Uzan C, Zelek L, Spielmann M, Penault-Llorca F, Namer M, Delaloge S

Bull Cancer. 2020 Apr 1;:

Socio-economic and occupational outcomes of long-term survivors of gynaecological cancer: A French population-based study.

Mamguem Kamga A, Dumas A, Joly F, Simon J, Billa O, Poillot ML, Jolimoy G, Roignot P, Coutant C, Arveux P, Dabakuyo-Yonli TS

Eur J Cancer Care (Engl). 2020 Mar 25;:e13235

[Guidelines for surgical management of gynaecological cancer during pandemic COVID-19 period - FRANCOGYN group for the CNGOF].

Akladios C, Azais H, Ballester M, Bendifallah S, Bolze PA, Bourdel N, Bricou A, Canlorbe G, Carcopino X, Chauvet P, Collinet P, Coutant C, Dabi Y, Dion L, Gauthier T, Graesslin O, Huchon C, Koskas M, Kridelka F, Lavoue V, Lecointre L, Mezzadri M, Mimoun C, Ouldamer L, Raimond E, Touboul C

Gynecol Obstet Fertil Senol. 2020 Mar 25;:

[Prediction performances of F-FDG PET and CGFL/Curie nomogram after preoperative chemotherapy in Breast cancer].

Vincent L, Jankowski C, Arnould L, Coudert B, Rouzier R, Reyal F, Humbert O, Coutant C

Gynecol Obstet Fertil Senol. 2020 Mar 20;:

Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study.

Chanteloup G, Cordonnier M, Isambert N, Bertaut A, Hervieu A, Hennequin A, Luu M, Zanetta S, Coudert B, Bengrine L, Desmoulins I, Favier L, Lagrange A, Pages PB, Gutierrez I, Lherminier J, Avoscan L, Jankowski C, Rébé C, Chevriaux A, Padeano MM, Coutant C, Ladoire S, Causeret S, Arnould L, Charon-Barra C, Cottet V, Blanc J, Binquet C, Bardou M, Garrido C, Gobbo J

J Extracell Vesicles. 2020 ;9(1):1766192

Impact of Breast Cancer Treatment on Employment: Results of a Multicenter Prospective Cohort Study (CANTO).

Dumas A, Vaz Luis I, Bovagnet T, El Mouhebb M, Di Meglio A, Pinto S, Charles C, Dauchy S, Delaloge S, Arveux P, Coutant C, Cottu P, Lesur A, Lerebours F, Tredan O, Vanlemmens L, Levy C, Lemonnier J, Mesleard C, Andre F, Menvielle G

J. Clin. Oncol.. 2019 Dec 13;:JCO1901726

Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).

Lecointre L, Velten M, Lodi M, Saadeh R, Lavoué V, Ouldamer L, Bendifallah S, Koskas M, Bolze PA, Collinet P, Canlorbe G, Touboul C, Huchon C, Coutant C, Faller E, Boisramé T, Gantzer J, Martin D, Baldauf JJ, Akladios C, Ballester M

Eur. J. Obstet. Gynecol. Reprod. Biol.. 2019 Dec 6;245:64-72

Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.

Kaboré EG, Guenancia C, Vaz-Luis I, Di Meglio A, Pistilli B, Coutant C, Cottu P, Lesur A, Petit T, Dalenc F, Rouanet P, Arnaud A, Arsene O, Ibrahim M, Wassermann J, Boileau-Jolimoy G, Martin AL, Lemonnier J, André F, Arveux P

PLoS Med.. 2019 Dec;16(12):e1002989

[Strategies in case of metastatic sentinel lymph node in breast cancer].

Costaz H, Rouffiac M, Boulle D, Arnould L, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Vincent L, Jankowski C, Coutant C

Bull Cancer. 2019 Nov 4;:

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.

Ferreira AR, Di Meglio A, Pistilli B, Gbenou AS, El-Mouhebb M, Dauchy S, Charles C, Joly F, Everhard S, Lambertini M, Coutant C, Cottu P, Lerebours F, Petit T, Dalenc F, Rouanet P, Arnaud A, Martin A, Berille J, Ganz PA, Partridge AH, Delaloge S, Michiels S, Andre F, Vaz-Luis I

Ann. Oncol.. 2019 Nov;30(11):1784-1795

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.

Ferreira AR, Di Meglio A, Pistilli B, Gbenou AS, El-Mouhebb M, Dauchy S, Charles C, Joly F, Everhard S, Lambertini M, Coutant C, Cottu P, Lerebours F, Petit T, Dalenc F, Rouanet P, Arnaud A, Martin A, Berille J, Ganz PA, Partridge AH, Delaloge S, Michiels S, Andre F, Vaz-Luis I

Ann. Oncol.. 2019 Oct 8;:

Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass F-FDG PET/CT.

Payan N, Presles B, Brunotte F, Coutant C, Desmoulins I, Vrigneaud JM, Cochet A

Eur. J. Nucl. Med. Mol. Imaging. 2019 Aug 8;:

Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.

Scholl S, Popovic M, de la Rochefordiere A, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M, Samuels S, Zijlmans H, Kenter G, Hillemanns P, Dema S, Dema A, Malenkovic G, Djuran B, Floquet A, Garbay D, Guyon F, Colombo PE, Fabbro M, Kerr C, Ngo C, Lecuru F, Campo ERD, Coutant C, Marchal F, Mesgouez-Nebout N, Fourchotte V, Feron JG, Morice P, Deutsch E, Wimberger P, Classe JM, Gleeson N, von der Leyen H, Minsat M, Dubot C, Gestraud P, Kereszt A, Nagy I, Balint B, Berns E, Jordanova E, Saint-Jorre N, Savignoni A, Servant N, Hupe P, de Koning L, Fumoleau P, Rouzier R, Kamal M

EBioMedicine. 2019 Apr 2;:

Combination of breast imaging parameters obtained from F-FDG PET and CT scan can improve the prediction of breast-conserving surgery after neoadjuvant chemotherapy in luminal/HER2-negative breast cancer.

Grapin M, Coutant C, Riedinger JM, Ladoire S, Brunotte F, Cochet A, Humbert O

Eur J Radiol. 2019 Apr;113:81-88

Saved by the evidence: Hyperthermic intraperitoneal chemotherapy still has a role to play in ovarian cancer.

Lavoué V, Bakrin N, Bolze PA, Bendifallah S, Collinet P, Graesslin O, Ballester M, Akladios C, Carcopino X, Bricou A, Koskas M, Canlorbe G, Coutant C, Ouldamer L, Daraï E, Touboul C, Huchon C,

Eur J Surg Oncol. 2019 Mar 29;:

Lymphadenectomy in elderly patients with high-intermediate-risk, high-risk or advanced endometrial cancer: Time to move from personalized cancer medicine to personalized patient medicine!

Racin A, Raimond E, Bendifallah S, Nyangoh Timoh K, Ouldamer L, Canlorbe G, Hudry N, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Koskas M, Ballester M, Daraï E, Levêque J, Lavoue V,

Eur J Surg Oncol. 2019 Feb 18;:

Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit.

de Nonneville A, Jauffret C, Gonçalves A, Classe JM, Cohen M, Reyal F, Mazouni C, Chauvet MP, Chopin N, Colombo PE, Jouve E, Darai E, Rouzier R, Coutant C, Gimbergues P, Azuar AS, de Lara CT, Lambaudie E, Houvenaeghel G

Breast Cancer Res. Treat.. 2019 Feb 13;:

[Hyperthermic intra-peritoneal chemotherapy (HIPEC) saved by evidence-based medecine: Ovarian carcinomatosis, HIPEC's favorite target?]

Lavoué V, Bendifallah S, Collinet P, Graesslin O, Ballester M, Akladios C, Carcopino X, Bricou A, Koskas M, Canlorbe G, Coutant C, Bolze PA, Ouldamer L, Daraï E, Touboul C, Huchon C,

Bull Cancer. 2019 Feb 11;:

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group.

Reboux PA, Azaïs H, Canova CH, Bendifallah S, Ouldamer L, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester M, Lévêque J, Lavoué V, Koskas M, Uzan C, Canlorbe G

J Gynecol Oncol. 2019 Feb 7;:

Does lymphadenectomy improve survival in patients with intermediate risk endometrial cancer? A multicentric study from the FRANCOGYN Research Group.

Bougherara L, Azaïs H, Béhal H, Canlorbe G, Ballester M, Bendifallah S, Coutant C, Lavoue V, Ouldamer L, Graesslin O, Touboul C, Estevez JP, Collinet P

Int. J. Gynecol. Cancer. 2019 Feb;29(2):282-289

Tubular and mucinous breast cancer: results of a cohort of 917 patients.

Roux P, Knight S, Cohen M, Classe JM, Mazouni C, Chauvet MP, Reyal F, Colombo PE, Jouve E, Chopin N, Daraï E, Coutant C, Lambaudie E, Houvenaeghel G

Tumori. 2019 Feb;105(1):55-62

Incidence, patterns and prognosis of first distant recurrence after surgically treated early stage endometrial cancer: Results from the multicentre FRANCOGYN study group.

Ouldamer L, Bendifallah S, Body G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Bricou A, Lavoué V, Lévêque J, Daraï E, Ballester M,

Eur J Surg Oncol. 2019 Jan 19;:

Long-Term Gynecological Cancer Survivors in Côte d'Or: Health-Related Quality of Life and Living Conditions.

Mamguem Kamga A, Dumas A, Joly F, Billa O, Simon J, Poillot ML, Darut-Jouve A, Coutant C, Fumoleau P, Arveux P, Dabakuyo-Yonli TS

Oncologist. 2018 Dec 21;:

Therapeutic value of surgical paraaortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group.

Dabi Y, Simon V, Carcopino X, Bendifallah S, Ouldamer L, Lavoue V, Canlorbe G, Raimond E, Coutant C, Graesslin O, Collinet P, Bricou A, Daraï E, Huchon C, Ballester M, Haddad B, Touboul C,

J Transl Med. 2018 Nov 26;16(1):326

Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast.

De Nonneville A, Jauffret C, Gonçalves A, Classe JM, Cohen M, Reyal F, Mazouni C, Chauvet MP, Chopin N, Colombo PE, Jouve E, Darai E, Rouzier R, Coutant C, Gimbergues P, Azuar AS, Tunon de Lara C, Lambaudie E, Houvenaeghel G

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii62

Benefit of adjuvant systemic therapies in HR+ HER2- pT1ab node-negative breast carcinomas.

De Nonneville A, Gonçalves A, Boher JM, Classe JM, Cohen M, Colombo PE, Reyal F, Chauvet MP, Jouve E, Darai E, Blache G, Coutant C, Gimbergues P, Mazouni C, Rouzier R, Villet R, Crochet P, Azuar AS, Lambaudie E, Houvenaeghel G

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii63

Breast cancer (BC) related fatigue: A longitudinal investigation of its prevalence, domains and correlates.

Vaz Luis I, Di Meglio A, El-Mouhebb M, Dumas A, Charles C, Menvielle G, Mesleard C, Martin AL, Cottu PH, Lerebours F, Coutant C, Lesur A, Dauchy S, Arveux P, Delaloge S, Lin N, Ganz P, Partridge AH, Michiels S, André F

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii605

Physical activity (PA) and patterns of quality of life (QOL) after adjuvant chemotherapy (CT) for breast cancer (BC).

Di Meglio A, El-Mouhebb M, Michiels S, Carene D, Everhard S, Martin AL, Cottu PH, Lerebours F, Coutant C, Lesur A, Tredan O, Soulie P, Vanlemmens L, Arveux P, Delaloge S, Ganz P, André F, Partridge AH, Jones L, Vaz-Luis I

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii755

Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact.

Houvenaeghel G, de Nonneville A, Cohen M, Classe JM, Reyal F, Mazouni C, Chopin N, Martinez A, Daraï E, Coutant C, Colombo PE, Gimbergues P, Chauvet MP, Azuar AS, Rouzier R, de Lara CT, Muracciole X, Agostini A, Gonçalves A, Lambaudie E

Breast Cancer Res. Treat.. 2018 Sep 20;:

Change in hazard rates of recurrence over time following diagnosis of endometrial cancer: An age stratified multicentre study from the FRANCOGYN group.

Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Lavoué V, Lévêque J, Bricou A, Huchon C, Daraï E, Ballester M,

Eur J Surg Oncol. 2018 Jul 31;:

A Proposal for a Classification for Recurrent Endometrial Cancer: Analysis of a French Multicenter Database From the FRANCOGYN Study Group.

Bricou A, Bendifallah S, Daix-Moreux M, Ouldamer L, Lavoue V, Benbara A, Huchon C, Canlorbe G, Raimond E, Coutant C, Graesslin O, Collinet P, Carcopino X, Touboul C, Daraï E, Carbillon L, Ballester M,

Int. J. Gynecol. Cancer. 2018 Jul 10;:

Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer.

Dabi Y, Willecocq C, Ballester M, Carcopino X, Bendifallah S, Ouldamer L, Lavoue V, Canlorbe G, Raimond E, Coutant C, Graesslin O, Collinet P, Bricou A, Huchon C, Daraï E, Haddad B, Touboul C,

J Transl Med. 2018 Jun 14;16(1):163

Pattern of breast cancer blood flow and metabolism, assessed using dual-acquisition FDG PET: correlation with tumor phenotypic features and pathological response to neoadjuvant chemotherapy.

Humbert O, Lasserre M, Bertaut A, Fumoleau P, Coutant C, Brunotte F, Cochet A

J. Nucl. Med.. 2018 Feb 9;:

Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries.

Cortet M, Bertaut A, Molinié F, Bara S, Beltjens F, Coutant C, Arveux P

BMC Cancer. 2018 02 7;18(1):161

Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer.

Gonssaud B, Goussot V, Berriolo-Riedinger A, Saïtta-Aribau E, Coutant C, Cochet A, Fumoleau P, Riedinger JM

Ann. Biol. Clin. (Paris). 2017 Aug;75(4):421-429

Patterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN group.

Rousselin A, Bendifallah S, Nyangoh Timoh K, Ouldamer L, Canlorbe G, Raimond E, Hudry N, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester M, Levêque J, Lavoue V

Eur J Surg Oncol. 2017 Aug;:

Prognostic value of local relapse for patients with endometrial cancer.

Dabi Y, Uzan J, Bendifallah S, Ouldamer L, Lavoué V, Canlorbe G, Raimond E, Coutant C, Graesslin O, Collinet P, Bricou A, Daraï E, Ballester M, Haddad B, Touboul C,

Eur J Surg Oncol. 2017 Aug;:

Evaluation and Selection of Quality Indicators for the Management of Endometrial Cancer.

Chenoz L, Phelippeau J, Barranger E, Bourdel N, Brun JL, Chereau E, Collinet P, Coutant C, Darai E, Deffieux X, Gautier T, Golfier F, Huchon C, Ouldamer L, Rouzier R, Koskas M

Int. J. Gynecol. Cancer. 2017 May;:

Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).

Houvenaeghel G, Lambaudie E, Cohen M, Classe JM, Reyal F, Garbay JR, Giard S, Chopin N, Martinez A, Rouzier R, Daraï E, Colombo PE, Coutant C, Gimbergues P, Azuar P, Villet R, Tunon de Lara C, Barranger E, Sabiani L, Goncalves A

Breast. 2017 May;34:24-33

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.

de Nonneville A, Gonçalves A, Zemmour C, Classe JM, Cohen M, Lambaudie E, Reyal F, Scherer C, Muracciole X, Colombo PE, Giard S, Rouzier R, Villet R, Chopin N, Darai E, Garbay JR, Gimbergues P, Sabiani L, Coutant C, Sabatier R, Bertucci F, Boher JM, Houvenaeghel G

Breast Cancer Res. Treat.. 2017 Apr;162(2):307-316

Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion.

Bendifallah S, Perrin M, Ouldamer L, Lavoué V, Canlorbe G, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Collinet P, Daraï E, Ballester M,

Surg Oncol. 2017 Mar;26(1):1-7

Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS

Rouzier R, Uzan C, Rousseau A, Guillot E, Zilberman S, Meyer C, Estevez P, Dupre PF, Kere D, Doridot V, D'halluin G, Fritel X, Pouget N, Jankowski C, Mazouni C, Simon T, Coutant C

Br. J. Cancer. 2017 Mar;:

Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.

Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Lavoué V, Lévêque J, Daraï E, Ballester M,

Ann. Surg. Oncol.. 2017 Jan;:

Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.

Bendifallah S, Ouldamer L, Lavoue V, Canlorbe G, Raimond E, Coutant C, Graesslin O, Touboul C, Collinet P, Daraï E, Ballester M,

Gynecol. Oncol.. 2017 Jan;144(1):107-112

Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis.

Jankowski C, Guiu S, Cortet M, Charon-Barra C, Desmoulins I, Lorgis V, Arnould L, Fumoleau P, Coudert B, Rouzier R, Coutant C, Reyal F

Breast Cancer Res. Treat.. 2017 Jan;161(1):73-81

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

Eliade M, Skrzypski J, Baurand A, Jacquot C, Bertolone G, Loustalot C, Coutant C, Guy F, Fumoleau P, Duffourd Y, Arnould L, Delignette A, Padéano MM, Lepage C, Raichon-Patru G, Boudrant A, Bône-Lépinoy MC, Villing AL, Charpin A, Peignaux K, Chevrier S, Vegran F, Ghiringhelli F, Boidot R, Sevenet N, Lizard S, Faivre L

Oncotarget. 2017 Jan;8(2):1957-1971

Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.

Poupon C, Bendifallah S, Ouldamer L, Canlorbe G, Raimond E, Hudry N, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester M, Levêque J, Lavoue V

Ann. Surg. Oncol.. 2016 Dec;:

Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.

Ouldamer L, Bendifallah S, Body G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Lavoué V, Lévêque J, Daraï E, Ballester M

Br. J. Cancer. 2016 Nov;115(11):1296-1303

Breast cancer in young women: Pathologic features and molecular phenotype.

Sabiani L, Houvenaeghel G, Heinemann M, Reyal F, Classe JM, Cohen M, Garbay JR, Giard S, Charitansky H, Chopin N, Rouzier R, Daraï E, Coutant C, Azuar P, Gimbergues P, Villet R, Tunon de Lara C, Lambaudie E

Breast. 2016 Oct;29:109-16

Atypical epithelial hyperplasia of the breast: state of the art.

Dion L, Racin A, Brousse S, Beltjens F, Cauchois A, Levêque J, Coutant C, Lavoué V

Expert Rev Anticancer Ther. 2016 Sep;16(9):943-53

[Breast cancer screening: On our way to the future].

Delaloge S, Bachelot T, Bidard FC, Espie M, Brain E, Bonnefoi H, Gligorov J, Dalenc F, Hardy-Bessard AC, Azria D, Jacquin JP, Lemonnier J, Jacot W, Goncalves A, Coutant C, Ganem G, Petit T, Penault-Lorca F, Debled M, Campone M, Levy C, Coudert B, Lortholary A, Venat-Bouvet L, Grenier J, Bourgeois H, Asselain B, Arvis J, Castro M, Tardivon A, Cox DG, Arveux P, Balleyguier C, André F, Rouzier R,

Bull Cancer. 2016 Sep;103(9):753-63

[Non-metastatic triple-negative breast cancer in 2016: Definitions and management].

Portha H, Jankowski C, Cortet M, Desmoulins I, Martin E, Lorgis V, Arnould L, Coutant C

Gynecol Obstet Fertil. 2016 Sep;44(9):492-504

Determinants of quality of life among long-term breast cancer survivors.

Chu WO, Dialla PO, Roignot P, Bone-Lepinoy MC, Poillot ML, Coutant C, Arveux P, Dabakuyo-Yonli TS

Qual Life Res. 2016 Aug;25(8):1981-90

[Assessment of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy in breast cancer: before or after?].

Coutant C, Jankowski C, Portha H, Barranger E

Gynecol Obstet Fertil. 2016 Jun;44(6):345-9

[Ductal carcinoma in situ diagnosis: 3 French national guidelines].

Cutuli B, Tunon De Lara C, Arnaud A, Bertheau P, Boulanger L, Boute V, Ceugnart L, Chauvet MP, Coutant C, De Cremoux P, Fourquet A, Hennequin C, Lesieur A, Lesur A, Lévy L, Vincent-Salomon A, Besnard S, Belorgey C

Ann Pathol. 2016 Jun;36(3):166-73

Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.

Lavoué V, Fritel X, Antoine M, Beltjens F, Bendifallah S, Boisserie-Lacroix M, Boulanger L, Canlorbe G, Catteau-Jonard S, Chabbert-Buffet N, Chamming's F, Chéreau E, Chopier J, Coutant C, Demetz J, Guilhen N, Fauvet R, Kerdraon O, Laas E, Legendre G, Mathelin C, Nadeau C, Naggara IT, Ngô C, Ouldamer L, Rafii A, Roedlich MN, Seror J, Séror JY, Touboul C, Uzan C, Daraï E,

Eur. J. Obstet. Gynecol. Reprod. Biol.. 2016 May;200:16-23

[CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3].

Riedinger JM, Goussot V, Desmoulins I, Lorgis V, Coutant C, Beltjens F, Lizard S, Fumoleau P

Bull Cancer. 2016 May;103(5):434-43

[Benign breast tumors: Recommendations of College National des Gynecologues Obstetriciens Francais (CNGOF) - Short text].

Lavoue V, Fritel X, Antoine M, Beltjens F, Bendifallah S, Boisserie-Lacroix M, Boulanger L, Canlorbe G, Catteau-Jonard S, Chabbert-Buffet N, Chamming's F, Chereau E, Chopier J, Coutant C, Demetz J, Guilhen N, Fauvet R, Kerdraon O, Laas E, Legendre G, Mathelin C, Nadeau C, Thomassin Naggara I, Ngo C, Ouldamer L, Rafii A, Roedlich MN, Seror J, Seror JY, Touboul C, Uzan C, Darai E

J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):1049-64

[Benign proliferative breast disease with and without atypia].

Coutant C, Canlorbe G, Bendifallah S, Beltjens F

J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):980-95

[Clinical practice guidelines: Benign breast tumor - Aims, methods and organization].

Lavoue V, Fritel X, Chopier J, Roedlich MN, Chamming's F, Mathelin C, Bendifallah S, Boisserie-Lacroix M, Canlorbe G, Chabbert-Buffet N, Coutant C, Guilhen N, Fauvet R, Laas E, Legendre G, Thomassin Naggara I, Ngo C, Ouldamer L, Seror J, Touboul C, Darai E

J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):898-903

[Lobular invasive breast cancer prognostic factors: About 940 patients].

Jauffret C, Houvenaeghel G, Classe JM, Garbay JR, Giard S, Charitansky H, Cohen M, Belichard C, Faure C, Darai E, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Coutant C, Dravet F, Chauvet MP, Chereau Ewald E, Penault-Llorca F, Goncalves A, Lambaudie E

Gynecol Obstet Fertil. 2015 Nov;43(11):712-7

Patient age and breast resection weight affect immediate postmastectomy breast reconstruction in ductal carcinoma in situ.

Burnier P, Hudry D, See LA, Duvernay A, Roche M, Loustalot C, Zwetyenga N, Coutant C

J Plast Reconstr Aesthet Surg. 2015 Oct 14. pii: S1748-6815(15)00457-X

[Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer].

Konan S, Goussot V, Desmoulins I, Lorgis V, Coutant C, Fumoleau P, Beltjens F, Dalban C, Lizard S, Riedinger JM

Bull Cancer. 2015 Oct;102(10):834-44

Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma.

Delpech Y, Bashour SI, Lousquy R, Rouzier R, Hess K, Coutant C, Barranger E, Esteva FJ, Ueno NT, Pusztai L, Ibrahim NK

Br J Cancer. 2015 Sep 22

Impact of age-related socio-economic and clinical determinants of quality of life among long-term breast cancer survivors.

Dialla PO, Chu WO, Roignot P, Bone-Lepinoy MC, Poillot ML, Coutant C, Arveux P, Dabakuyo-Yonli TS

Maturitas. 2015 Jul;81(3):362-70

Identification of biomarkers including 18FDG-PET/CT for early prediction of response to neoadjuvant chemotherapy in Triple Negative Breast Cancer.

Humbert O, Riedinger JM, Charon-Barra C, Berriolo-Riedinger A, Desmoulins I, Lorgis V, Kanoun S, Coutant C, Fumoleau P, Cochet A, Brunotte F

Clin Cancer Res. 2015 Jun 30. pii: clincanres.0384.2015.

Evaluation of axillary involvement by ultrasound-guided lymph node biopsy: A prospective study.

Jankowski C, Hudry D, Vaillant D, Varbedian O, Mejean N, Guy F, Feutray S, Coutant C

Gynecol Obstet Fertil. 2015 May 15. pii: S1297-9589(15)00145-9

Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study.

Canlorbe G, Bendifallah S, Laas E, Raimond E, Graesslin O, Hudry D, Coutant C, Touboul C, Bleu G, Collinet P, Cortez A, Darai E, Ballester M

Ann Surg Oncol. 2015 May 8.

A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis.

Bendifallah S, Canlorbe G, Laas E, Huguet F, Coutant C, Hudry D, Graesslin O, Raimond E, Touboul C, Collinet P, Cortez A, Bleu G, Darai E, Ballester M

Ann Surg Oncol. 2015 Apr 14.

Just how accurate are the major risk stratification systems for early-stage endometrial cancer?

Bendifallah S, Canlorbe G, Collinet P, Arsene E, Huguet F, Coutant C, Hudry D, Graesslin O, Raimond E, Touboul C, Darai E, Ballester M

Br J Cancer. 2015 Mar 3;112(5):793-801

External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter study.

Bendifallah S, Canlorbe G, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Huguet F, Cortez A, Darai E, Ballester M

Am J Obstet Gynecol. 2015 Jan;212(1):56.e1-7

French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring System.

Bendifallah S, Canlorbe G, Arsene E, Collinet P, Huguet F, Coutant C, Hudry D, Graesslin O, Raimond E, Touboul C, Darai E, Ballester M

Ann Surg Oncol. 2015 Jan 7.

A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study.

Bendifallah S, Canlorbe G, Huguet F, Coutant C, Hudry D, Graesslin O, Raimond E, Touboul C, Collinet P, Bleu G, Daraï E, Ballester M

Ann. Surg. Oncol.. 2014 Dec;21(13):4239-45

Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.

Canlorbe G, Bendifallah S, Raimond E, Graesslin O, Hudry D, Coutant C, Touboul C, Bleu G, Collinet P, Darai E, Ballester M

Ann Surg Oncol. 2014 Dec 12.

Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.

Degrolard-Courcet E, Sokolowska J, Padeano MM, Guiu S, Bronner M, Chery C, Coron F, Lepage C, Chapusot C, Loustalot C, Jouve JL, Hatem C, Ferrant E, Martin L, Coutant C, Baurand A, Couillault G, Delignette A, El Chehadeh S, Lizard S, Arnould L, Fumoleau P, Callier P, Mugneret F, Philippe C, Frebourg T, Jonveaux P, Faivre L

Eur J Hum Genet. 2014 Aug;22(8):979-87

HER2-positive breast cancer: (1)(8)F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy.

Humbert O, Cochet A, Riedinger JM, Berriolo-Riedinger A, Arnould L, Coudert B, Desmoulins I, Toubeau M, Dygai-Cochet I, Guiu S, Coutant C, Fumoleau P, Brunotte F

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1525-33

[Endometrial carcinoma. Application of the guidelines of 2010: multicentre trial].

Raimond E, Canlorbe G, Bendifallah S, Hudry D, Selvi F, Ballester M, Coutant C, Graesslin O, Darai E

Bull Cancer. 2014 Jul-Aug;101(7-8):703-13

Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study.

Raimond E, Ballester M, Hudry D, Bendifallah S, Daraï E, Graesslin O, Coutant C

Gynecol. Oncol.. 2014 Jun;133(3):506-11

A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.

Bendifallah S, Canlorbe G, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Huguet F, Cortez A, Darai E, Ballester M

Br J Cancer. 2014 May 27;110(11):2640-6

(1)(8)F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.

Cochet A, Dygai-Cochet I, Riedinger JM, Humbert O, Berriolo-Riedinger A, Toubeau M, Guiu S, Coutant C, Coudert B, Fumoleau P, Brunotte F

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):428-37

Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study.

Houvenaeghel G, Goncalves A, Classe JM, Garbay JR, Giard S, Charytensky H, Cohen M, Belichard C, Faure C, Uzan S, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Lambaudie E, Coutant C, Dravet F, Chauvet MP, Chereau Ewald E, Penault-Llorca F, Esterni B

Ann Oncol. 2014 Mar;25(3):623-8

Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.

Humbert O, Berriolo-Riedinger A, Cochet A, Gauthier M, Charon-Barra C, Guiu S, Desmoulins I, Toubeau M, Dygai-Cochet I, Coutant C, Fumoleau P, Brunotte F

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):416-27

Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study.

Hequet D, Marchand E, Place V, Fourchotte V, De La Rochefordiere A, Dridi S, Coutant C, Lecuru F, Bats AS, Koskas M, Bretel JJ, Bricou A, Delpech Y, Barranger E

Eur J Surg Oncol. 2013 Dec;39(12):1428-34

Impact of sentinel node biopsy on long-term quality of life in breast cancer patients.

De Gournay E, Guyomard A, Coutant C, Boulet S, Arveux P, Causeret S, Gouy S, Padeano MM, Loustalot C, Sauzedde JM, Smail M, Combier JP, Chevillote P, Rosburger C, Bonnetain F, Fraisse J, Dabakuyo-Yonli TS

Br J Cancer. 2013 Nov 26;109(11):2783-91

The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.

Delpech Y, Bricou A, Lousquy R, Hudry D, Jankowski C, Willecocq C, Thoury A, Loustalot C, Coutant C, Barranger E

Ann Surg Oncol. 2013 Aug;20(8):2556-61

Predictive models for metastatic non-sentinel lymph nodes in cases of positive sentinel lymph nodes in breast cancer.

Chereau E, Hudry D, Lambaudie E, Cohen M, Houvenaeghel G, Coutant C

Oncologie. 2013 Jun;15(6):304-10.

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas.

Delpech Y, Coutant C, Hsu L, Barranger E, Iwamoto T, Barcenas CH, Hortobagyi GN, Rouzier R, Esteva FJ, Pusztai L

Br J Cancer. 2013 Feb 5;108(2):285-91

Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer.

Delpech Y, Wu Y, Hess KR, Hsu L, Ayers M, Natowicz R, Coutant C, Rouzier R, Barranger E, Hortobagyi GN, Mauro D, Pusztai L

Breast Cancer Res Treat. 2012 Sep;135(2):619-27

Comparison of three models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: A retrospective study of 77 patients.

Terrier C, Tariel O, Coutant C, De Saint Hilaire P, Devouassoux M, Rudigoz RC, Dubernard G

J Gynecol Obstet Biol Reprod (Paris). 2012 May;41(3):227-34

Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors.

Frati A, Chereau E, Coutant C, Bezu C, Antoine M, Chopier J, Daraï E, Uzan S, Gligorov J, Rouzier R

Breast Cancer Res. Treat.. 2012 Apr;132(2):601-7

Nomogram to predict pregnancy rate after ICSI-IVF cycle in patients with endometriosis.

Ballester M, Oppenheimer A, d'Argent EM, Touboul C, Antoine JM, Coutant C, Daraï E

Hum. Reprod.. 2012 Feb;27(2):451-6

Antibacterial-coated suture in reducing surgical site infection in breast surgery: a prospective study.

Laas E, Poilroux C, Bézu C, Coutant C, Uzan S, Rouzier R, Chéreau E

Int J Breast Cancer. 2012 ;2012:819578

Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer.

Chéreau E, Feron JG, Ballester M, Coutant C, Bezu C, Rouzier R, Touboul E, Daraï E

Br. J. Cancer. 2012 Jan;106(1):39-44

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.

Reyal F, Belichard C, Rouzier R, de Gournay E, Senechal C, Bidard FC, Pierga JY, Cottu P, Lerebours F, Kirova Y, Feron JG, Fourchotte V, Vincent-Salomon A, Guinebretiere JM, Sigal-Zafrani B, Sastre-Garau X, De Rycke Y, Coutant C

PLoS One. 2012;7(10):e47390

External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery.

Chereau E, Lavoue V, Ballester M, Coutant C, Selle F, Cortez A, Daraï E, Leveque J, Rouzier R

Anticancer Res.. 2011 Dec;31(12):4469-74

The usefulness of a preoperative compact imager, a hand-held gamma-camera for breast cancer sentinel node biopsy: final results of a prospective double-blind, clinical study.

Kerrou K, Pitre S, Coutant C, Rouzier R, Ancel PY, Lebeaux C, Huchet V, Montravers F, Pascal O, Duval MA, Lefebvre F, Menard L, Uzan S, Charon Y, Barranger E

J. Nucl. Med.. 2011 Sep;52(9):1346-53

Interest in cavity shaving in breast conservative treatment does not depend on lumpectomy technique.

Feron JG, Nguyen A, Bézu C, Antoine M, Darai E, Coutant C, Rouzier R, Uzan S

Breast. 2011 Aug;20(4):358-64

Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.

Coutant C, Rouzier R, Qi Y, Lehmann-Che J, Bianchini G, Iwamoto T, Hortobagyi GN, Symmans WF, Uzan S, Andre F, de Thé H, Pusztai L

Clin. Cancer Res.. 2011 Apr;17(8):2591-601

Laparoscopic pelvic lymph node dissection.

Ballester M, Chéreau E, Coutant C, Daraï E, Rouzier R

J Visc Surg. 2011 Apr;148(2):e111-6

Urinary dysfunction after colorectal resection for endometriosis: results of a prospective randomized trial comparing laparoscopy to open surgery.

Ballester M, Chereau E, Dubernard G, Coutant C, Bazot M, Daraï E

Am. J. Obstet. Gynecol.. 2011 Apr;204(4):303.e1-6

Anaphylactic response to blue dye during sentinel lymph node biopsy.

Bézu C, Coutant C, Salengro A, Daraï E, Rouzier R, Uzan S

Surg Oncol. 2011 Mar;20(1):e55-9

Discordance with local guidelines for adjuvant chemotherapy in breast cancer: reasons and effect on survival.

Chéreau E, Coutant C, Gligorov J, Lesieur B, Antoine M, Daraï E, Uzan S, Rouzier R

Clin. Breast Cancer. 2011 Mar;11(1):46-51

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

Iwamoto T, Bianchini G, Booser D, Qi Y, Coutant C, Shiang CY, Santarpia L, Matsuoka J, Hortobagyi GN, Symmans WF, Holmes FA, O'Shaughnessy J, Hellerstedt B, Pippen J, Andre F, Simon R, Pusztai L

J. Natl. Cancer Inst.. 2011 Feb;103(3):264-72

Transvaginal hydrolaparoscopy.

Daraï E, Coutant C, Dessolle L, Ballester M

Minerva Ginecol. 2011 Feb;63(1):31-8

[Complications of radical surgery for advanced ovarian cancer].

Chéreau E, Ballester M, Lesieur B, Selle F, Coutant C, Rouzier R, Daraï E

Gynecol Obstet Fertil. 2011 Jan;39(1):21-7

Laparoscopic versus laparotomic radical en bloc hysterectomy and colorectal resection for endometriosis.

Daraï E, Ballester M, Chereau E, Coutant C, Rouzier R, Wafo E

Surg Endosc. 2010 Dec;24(12):3060-7

Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications.

Bendifallah S, Werkoff G, Borie-Moutafoff C, Antoine M, Chopier J, Gligorov J, Uzan S, Coutant C, Rouzier R

Surg Oncol. 2010 Dec;19(4):e115-23

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

Tabchy A, Valero V, Vidaurre T, Lluch A, Gomez H, Martin M, Qi Y, Barajas-Figueroa LJ, Souchon E, Coutant C, Doimi FD, Ibrahim NK, Gong Y, Hortobagyi GN, Hess KR, Symmans WF, Pusztai L

Clin. Cancer Res.. 2010 Nov;16(21):5351-61